A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
10.1038/s41467-018-03441-3
Saved in:
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Nature Publishing Group
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/178423 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-178423 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1784232024-05-08T09:51:10Z A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage Ladds, M.J.G.W Van Leeuwen, I.M.M Drummond, C.J MEDICINE antineoplastic agent dihydroorotate dehydrogenase dihydroorotate dehydrogenase inhibitor hz 00 hz 05 nutlin 3 protein p53 unclassified drug antineoplastic agent enzyme inhibitor indazole derivative oxidoreductase protein p53 biodegradation cancer cell chemical compound crystal structure enzyme enzyme activity growth inhibitor protein tumor animal cell animal experiment animal model antineoplastic activity Article cancer cell cancer combination chemotherapy cell cycle S phase cell killing chirality controlled study crystal structure drug identification drug mechanism enantiomer enzyme inhibition human human cell in vivo study malignant neoplasm melanoma mouse nonhuman protein degradation protein denaturation protein synthesis tumor growth antagonists and inhibitors cell cycle cell proliferation chemistry drug effect enzymology genetics metabolism neoplasm protein degradation tumor cell line Antineoplastic Agents Cell Cycle Cell Line, Tumor Cell Proliferation Enzyme Inhibitors Humans Indazoles Neoplasms Oxidoreductases Acting on CH-CH Group Donors Proteolysis Tumor Suppressor Protein p53 10.1038/s41467-018-03441-3 Nature Communications 9 1 1107 2020-10-20T09:53:37Z 2020-10-20T09:53:37Z 2018 Article Ladds, M.J.G.W, Van Leeuwen, I.M.M, Drummond, C.J (2018). A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications 9 (1) : 1107. ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-018-03441-3 2041-1723 https://scholarbank.nus.edu.sg/handle/10635/178423 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Nature Publishing Group Unpaywall 20201031 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
antineoplastic agent dihydroorotate dehydrogenase dihydroorotate dehydrogenase inhibitor hz 00 hz 05 nutlin 3 protein p53 unclassified drug antineoplastic agent enzyme inhibitor indazole derivative oxidoreductase protein p53 biodegradation cancer cell chemical compound crystal structure enzyme enzyme activity growth inhibitor protein tumor animal cell animal experiment animal model antineoplastic activity Article cancer cell cancer combination chemotherapy cell cycle S phase cell killing chirality controlled study crystal structure drug identification drug mechanism enantiomer enzyme inhibition human human cell in vivo study malignant neoplasm melanoma mouse nonhuman protein degradation protein denaturation protein synthesis tumor growth antagonists and inhibitors cell cycle cell proliferation chemistry drug effect enzymology genetics metabolism neoplasm protein degradation tumor cell line Antineoplastic Agents Cell Cycle Cell Line, Tumor Cell Proliferation Enzyme Inhibitors Humans Indazoles Neoplasms Oxidoreductases Acting on CH-CH Group Donors Proteolysis Tumor Suppressor Protein p53 |
spellingShingle |
antineoplastic agent dihydroorotate dehydrogenase dihydroorotate dehydrogenase inhibitor hz 00 hz 05 nutlin 3 protein p53 unclassified drug antineoplastic agent enzyme inhibitor indazole derivative oxidoreductase protein p53 biodegradation cancer cell chemical compound crystal structure enzyme enzyme activity growth inhibitor protein tumor animal cell animal experiment animal model antineoplastic activity Article cancer cell cancer combination chemotherapy cell cycle S phase cell killing chirality controlled study crystal structure drug identification drug mechanism enantiomer enzyme inhibition human human cell in vivo study malignant neoplasm melanoma mouse nonhuman protein degradation protein denaturation protein synthesis tumor growth antagonists and inhibitors cell cycle cell proliferation chemistry drug effect enzymology genetics metabolism neoplasm protein degradation tumor cell line Antineoplastic Agents Cell Cycle Cell Line, Tumor Cell Proliferation Enzyme Inhibitors Humans Indazoles Neoplasms Oxidoreductases Acting on CH-CH Group Donors Proteolysis Tumor Suppressor Protein p53 Ladds, M.J.G.W Van Leeuwen, I.M.M Drummond, C.J A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage |
description |
10.1038/s41467-018-03441-3 |
author2 |
MEDICINE |
author_facet |
MEDICINE Ladds, M.J.G.W Van Leeuwen, I.M.M Drummond, C.J |
format |
Article |
author |
Ladds, M.J.G.W Van Leeuwen, I.M.M Drummond, C.J |
author_sort |
Ladds, M.J.G.W |
title |
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage |
title_short |
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage |
title_full |
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage |
title_fullStr |
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage |
title_full_unstemmed |
A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage |
title_sort |
dhodh inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage |
publisher |
Nature Publishing Group |
publishDate |
2020 |
url |
https://scholarbank.nus.edu.sg/handle/10635/178423 |
_version_ |
1800914498562818048 |